Macular degeneration is a leading cause of visual impairment in people over 65 and can lead to blindness. One in three people will eventually suffer some degree of macular degeneration, which is caused by abnormal blood vessels under the retina, the light-sensitive part of the eye. We treat both the more common “dry” as well as the more dangerous “wet” forms of macular degeneration. While there is currently no cure for this disease, we offer the latest treatments to reduce the risk of vision loss and blindness. These include anti-VEGF drugs—which attack proteins that create the abnormal blood vessels that cause macular degeneration—and photodynamic therapy, in which patients ingest medication that is then activated with a laser.
On the Mayo Clinic Radio podcast, Dr. Sophie Bakri, a Mayo Clinic ophthalmologist and retina specialist, discusses macular degeneration, a common eye disorder with age. This interview originally aired Feb. 29, 2020.
Dry macular degeneration is a common eye disorder among people over 50. It causes blurred or reduced central vision, due to thinning of the macula (MAK-u-luh). The macula is the part of the retina responsible for clear vision in your direct line of sight.
Dry macular degeneration may first develop in one eye and then affect both. Over time your vision may worsen and affect your ability to do things such as read, drive and recognize faces. But this doesn’t mean you’ll lose all of your sight.
Early detection and self-care measures may delay vision loss due to dry macular degeneration.